Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.41 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29395469 | 0.92 | ALDH5A1 (0.50) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL1816905 | 0.90 | ALDH1A1 (0.59) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL25245965 | 0.89 | CYP2A6 (0.46) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL3006203 | 0.88 | EGFR (0.47) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL1814707 | 0.88 | PTGS1 (0.44) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL29178204 | 0.88 | CYP2A6 (0.41) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL4453443 | 0.88 | CYP2A6 (0.73) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL1815162 | 0.88 | HSD17B10 (0.73) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL28542466 | 0.88 | ALDH5A1 (0.46) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL1221196 | 0.86 | FFAR1 (0.44) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066528-A1 | Method for Synthesizing a Covalent Organic Framework Material | YOCOF MAT SUZHOU CO LTD (CN) | 2025-02-27 | — | — | US | claimed |
| CN-116178647-B | Cobalt cyclopentadiene-based covalent organic framework material, preparation method and application thereof | 中国石油大学(华东) | 2025-02-14 | — | — | CN | claimed |
| CN-119039550-A | Vinyl high-crystallinity covalent organic framework film, film sensor, preparation method and application thereof | 南开大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118852568-A | Efficient, green and universal fusion synthesis method for covalent organic frameworks | 浙江大学杭州国际科创中心 | 2024-10-29 | — | — | CN | claimed |
| CN-118526517-A | Method for adsorbing enterogenic protein combined uremic toxin and precursor thereof | 南开大学 | 2024-08-23 | — | — | CN | claimed |
| US-20240270883-A1 | COVALENT ORGANIC FRAMEWORK AND CATALYST, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF | ZHEJIANG UNIVERSITY (CN) | 2024-08-15 | — | — | US | claimed |
| CN-114773556-B | Green solid-phase synthesis method of covalent organic framework material | 耀科新材料(苏州)有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-117624521-A | Ionic covalent organic framework material, solid phase synthesis method and application thereof | 耀科新材料(苏州)有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2024037615-A1 | IONIC COVALENT ORGANIC FRAMEWORK MATERIAL, SOLID-PHASE SYNTHESIS METHOD THEREOF, AND USE THEREOF | 耀科新材料（天津）有限公司 | 2024-02-22 | — | — | WO | claimed |
| EP-4269471-A1 | COVALENT ORGANIC FRAMEWORK AND CATALYST, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF | Zhejiang University (CN) | 2023-11-01 | — | — | EP | claimed |
| WO-2023124952-A1 | GREEN SOLID-PHASE SYNTHESIS METHOD FOR COVALENT ORGANIC FRAMEWORK MATERIAL | 张振杰 | 2023-07-06 | — | — | WO | claimed |
| CN-116178647-A | Cobalt cyclopentadiene-based covalent organic framework material, preparation method and application thereof | 中国石油大学(华东) | 2023-05-30 | — | — | CN | claimed |
| CN-114773556-A | Green solid-phase synthesis method of covalent organic framework material | 南开大学 | 2022-07-22 | — | — | CN | claimed |
| WO-2022133843-A1 | COVALENT ORGANIC FRAMEWORK AND CATALYST, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF | 浙江大学 | 2022-06-30 | — | — | WO | claimed |
| CN-120136762-B | Application of diamidino-containing compound and pharmaceutically-acceptable salt in antifungal | 中国医学科学院医药生物技术研究所 | 2026-05-12 | — | — | CN | disclosed |
| CN-120192490-A | Quinoline type covalent organic framework material, cyano-modified quinoline type covalent organic framework material, and preparation method and application thereof | 广东工业大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-120136762-A | Application of diamidino-containing compound and pharmaceutically-acceptable salt in antifungal | 中国医学科学院医药生物技术研究所 | 2025-06-13 | — | — | CN | disclosed |
| US-5681504-A | LIQUID CRYSTAL DOPANTS | ROLIC AG (CH) | 1997-10-28 | — | — | US | disclosed |
| US-5498367-A | LIQUID CRYSTALS, 2-(PHENYL ETHYNYLPHENYL)-1,3-DIOXOLANE-4,5-DICARBOXYLATES | HOFFMANN-LA ROCHE INC. (US) | 1996-03-12 | — | — | US | disclosed |
| EP-0675188-A1 | Optically active tolane derivative | F. Hoffmann-La Roche AG (CH) | 1995-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270883-A1 | COVALENT ORGANIC FRAMEWORK AND CATALYST, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF | CYP4F11, CYP4F12, CYP2F1 | CYP2A6 432/4885HSD17B10 399/4885ALDH5A1 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.